EXECUTIVE ENGAGEMENTS
POOL
5872
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
942
Interactions with Platform & by Email
PARTICIPANTS
176
Unique # Participated
VALIDATIONS
38
Responses Validated*
COMPANIES
110
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
214
PAGES
511
EDITION
17
PRICE
USD 5450
CODE
MCP-1218
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global Hemoglobin A1C (HbA1C) Testing Market to Reach $1.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Hemoglobin A1C (HbA1C) Testing estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$723.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunoassays segment is readjusted to a revised 8.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $341.7 Million, While China is Forecast to Grow at 9% CAGR
The Hemoglobin A1C (HbA1C) Testing market in the U.S. is estimated at US$341.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$208.6 Million by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 6.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$184.2 Million by the year 2027.
Boronate Affinity Chromatography Segment to Record 6% CAGR
In the global Boronate Affinity Chromatography segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$147.2 Million in the year 2020 will reach a projected size of US$216.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.3% CAGR through the analysis period.
SELECT PLAYERS
A.Menarini Diagnostics Ltd.; Abbott Laboratories; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Diazyme Laboratories, Inc.; EKF Diagnostics Holdings Plc; HemoCue® AB; OSANG Healthcare Co., Ltd; PTS Diagnostics; Roche Diagnostics; Siemens Healthineers; Trinity Biotech plc
SEGMENTS
» Technology (Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays, Other Technologies) » End-Use (Hospitals & Clinics, Diagnostic Laboratories, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Impact of Covid-19 and a Looming Global Recession |
| Year 2021 in Review and Near-term Outlook |
| Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook |
| Competition |
| Hemoglobin A1C (HbA1C) Testing – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 33 Players Worldwide in 2022 (E) |
| HbA1c Devices: Critical Role in Monitoring & Management of Diabetes |
| Role of HbA1c Testing in Diabetes Diagnosis and Management |
| Interpretation of HbA1c in NGSP and IFCC Units as per the American Diabetes Association |
| Global Market Analysis and Prospects |
| World Hemoglobin A1C (HBA1C) Testing Market Set to Witness Rapid Growth |
| While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth |
| Chromatography-based Hb Testing Devices Lead Market |
| HbA1c Testing to Witness Skyrocketing Interest with Focus on POC Testing for Diabetes |
| Diabetes Screening to Receive Special Thrust from Rapid Point-Of-Care HbA1c Testing |
| Recent Market Activity |
| WORLD BRANDS |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand for HbA1c Monitoring Devices |
| EXHIBIT 1: World Diabetes and Population Statistics (2019, 2030 & 2045) |
| EXHIBIT 2: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045 |
| EXHIBIT 3: World Diabetes Prevalence (2000-2045P) |
| EXHIBIT 5: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045 |
| Diabetes Emerges as One of the Leading Causes of Mortality |
| EXHIBIT 6: Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019 |
| Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market |
| Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption |
| Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players |
| Laboratory-based HbA1c Testing Products/Analyzers of Select Players |
| Major Testing Methods in POC HbA1c Tests |
| High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market |
| EXHIBIT 9: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
| EXHIBIT 10: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 |
| Increasing Obesity Levels Underpins Market Growth |
| EXHIBIT 13: Average Per Capita Annual Health Expenditure (In US$) due to Obesity |
| EXHIBIT 14: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P |
| Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices |
| EXHIBIT 11: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023 |
| Variants & Derivatives Affecting Accuracy of HbA1c Testing |
| Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing |
| EXHIBIT 18: Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019 |
| EXHIBIT 19: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019 |
| Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis |
| Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing |
| Technology Developments Transform Diagnostics in Diabetes Care |
| Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring |
| Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease |
| HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes |
| Home HbA1C Testing Market |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Hemoglobin A1C (HbA1C) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027 |
| World Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Boronate Affinity Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Direct Enzymatic Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| JAPAN |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| CHINA |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| EUROPE |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| FRANCE |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| GERMANY |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| AUSTRALIA |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
| Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| INDIA |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
| India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| LATIN AMERICA |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
| Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| MIDDLE EAST |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
| Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| AFRICA |
| Hemoglobin A1C (HbA1C) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
| Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2012, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com